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of ICC, in a setting of 70% vaccination coverage. The incremental ratio of cost-
effectiveness (IRCE) was R$ 1,200 for each year of quality-adjusted life (QALY) 
saved. The sensitivity analysis confirms the robustness of this result, and 
duration of immunity was the parameter with greater variation in. 
CONCLUSIONS: Vaccination has a favorable profile in terms of cost-utility, and 
its inclusion in the immunization schedule would result in substantial reduction 
in incidence and mortality of ICC in amazonic region of Brazil.  
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COMPARISON OF SERVICE UTILIZATION AND ASSOCIATED EXPENDITURES 
BETWEEN PUBLICLY AND PRIVATELY INSURED CHILDREN WITH ASDS  
Doshi P, Li C 
University of Arkansas for Medical Sciences, Little Rock, AR, USA  
OBJECTIVES: The prevalence of Autism Spectrum Disorders (ASDs) has been 
increasing lately and treatment is expensive. Private insurers have historically 
provided lesser coverage for autism-related services than public insurers. This 
study compared the differences in health care expenditures and utilization 
between publicly and privately insured children with ASDs. METHODS: Data 
were from years 1997-2010 of the Medical Expenditure Panel Survey. 477 children 
with ASDs, of which 274 were privately insured and 184 had public insurance 
only, were identified. Expenditure measures (in 2010 dollars) included total 
health, home health and prescription expenditures and out-of-pocket 
expenditures on health and drugs. Utilization measures included the number of 
office-based visits, home health days and prescriptions. Generalized linear 
models, adjusted for sociodemographics and health status, were used to model 
utilization and expenditure to account for their skewness. STATA survey 
commands generated nationally representative estimates. RESULTS: Average 
total health care expenses were comparable for publicly and privately insured 
children with the latter having much higher out-of-pocket expenses ($1137.807 
vs $199.244). Publicly insured children used more prescriptions (13.52 vs 9.19) 
with lower out-of pocket expenses ($103.170 vs $206.964), and used more home 
health services (19.39 vs 7.67) with higher costs ($3,118.28 vs $782.43). After 
adjusting for sociodemographic differences and health status, no statistically 
significant differences in total health expenditures and utilization measures 
remained. However, publicly insured children spent 79% less (p < 0.000) and 63% 
less (p = 0.001) on average than privately insured children on out-of-pocket 
health and prescription expenditures respectively. CONCLUSIONS: Higher out-
of-pocket expenditures on health services and prescriptions for privately-insured 
children may be an indication of lower coverage for autism-related health 
services. State policies should correct this anomaly to reduce the burden on 
public insurers, as well as provide children with ASDs more options to get 
expensive treatment options covered.  
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DOSE RELATIVITY OF SEVELAMER HYDROCHLORIDE AND LANTHANUM 
CARBONATE UNDER REAL-WORLD CONDITIONS: IMPLICATIONS FOR 
MANAGEMENT OF PATIENTS WITH END-STAGE RENAL DISEASE AND 
HYPERPHOSPHATEMIA  
Copley JB1, Wilson RJ2, Keith MS1 
1Shire Pharmaceuticals, Wayne, PA, USA, 2Spica Consultants, Marlborough, UK  
OBJECTIVES: To determine the dose relativity of sevelamer hydrochloride (SH) 
and lanthanum carbonate (LC) monotherapy under real-world clinical conditions 
in the USA. METHODS: A post hoc analysis of an open-label, post-marketing study 
of patients (n = 2763) with end-stage renal disease (ESRD) in a real-world clinical 
setting in the USA. The analysis evaluated patients who converted from SH 
monotherapy at baseline to LC monotherapy for 16 weeks (12 week titration 
phase, 4 week maintenance period). Serum phosphate (P) levels and daily P 
binder dose were assessed at baseline and at weeks 12 and 16. RESULTS: A total 
of 953 patients were taking SH monotherapy at baseline; their mean SH dose  
was 7644±3660 mg/day and mean serum P level was 5.88±1.69 mg/dL. After  
16 weeks of LC monotherapy, mean LC dose was 2800±938 mg/day (SH:LC dose-
relativity 2.8) and mean P level was 5.93±1.85 mg/dL. In the subgroup of patients 
(n=191; 20%) receiving SH >7200 to ≤9600 mg/day (mean dose 9294±601 mg/day) 
at baseline, mean P level was 6.10±1.68 mg/dL. After LC treatment, their mean  
LC dose was 3018±800 mg/day (dose-relativity 3.1), and mean P level was 
6.42±1.88 mg/dL. Patients (n=192; 20%) receiving SH >9600 mg/day (mean dose 
13171±2388 mg/day) at baseline had a mean P level of 6.22±1.78 mg/dL. After LC 
treatment, their mean LC dose was 3156±808 mg/day (dose-relativity 4.2) and 
mean P level was 6.25±1.87 mg/dL. CONCLUSIONS: SH:LC dose relativity in the 
overall patient population was 2.8, in agreement with previous studies. However, 
the present study demonstrates that patients who require higher SH doses to 
maintain P control (>7200 mg/day; ~40% of patients) had higher SH:LC dose 
relativities (3.1–4.2). These findings have implications for the cost-effectiveness 
of P binder therapy in the treatment of patients with ESRD and 
hyperphosphatemia.  
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PRODUCTIVITY LOSS COSTS ATTRIBUTABLE TO OVERWEIGHT OR OBESITY  
IN WORKING ASTHMA PATIENTS IN THE UNITED STATES  
Choi IS1, Chang CW1, Kim CM2, Suh DC1 
1Chung-Ang University, Seoul, South Korea, 2Catholic University College of Medicine, Seoul, 
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OBJECTIVES: To estimate annual productivity loss costs attributable to being 
overweight or obese in working adults with asthma patients in the US. 
METHODS: Working asthma patients (18-64 years old) were identified using the 
2003-2009 Medical Expenditure Panel Survey (MEPS). Asthma patients were 
identified by self-reported diagnosis, Clinical Classification Codes of 128, or ICD-
9-CM code of 493 and the identified patients were classified as normal-weight 
(18.5≤BMI<25), overweight (25≤BMI<30), and obese (BMI≥30). Productivity loss 
costs, which were measured based on missed work days due to illness or injury 
for one year and the hourly wage, were estimated using a two-part model to 
adjust for patients with zero costs. To estimate the productivity loss costs 
attributable to being overweight or obese, costs were estimated by assuming 
every patient is overweight or obese (i.e., treating the indicator variable as equal 
to 1) and re-estimating by assuming every patient is normal (i.e., treating the 
indicator variable as equal to 0). Then, the mean differences between the two 
estimated costs were considered the productivity loss costs attributable to 
overweight or obesity in asthma patients. All costs were converted to 2011  
US dollars using the Consumer Price Index. RESULTS: Annual average 
productivity loss costs attributable to obesity were $697(95%CI:$614-$780) per 
patient, 45% higher than overweight (at $480, 95%CI:$397-$563) and 92% higher 
than normal (at $363, 95%CI:$298-$428). The productivity loss costs in working 
asthma patients increased as patients were obese, older, or female. Also, the 
productivity loss costs attributable to overweight or obesity in working asthma 
patients were estimated at $89 (95%CI:$87-$91) or $250 (95%CI:$246-$254) per 
person per year, respectively. CONCLUSIONS: The productivity lost costs 
attributable to overweight and obesity in working US adults with asthma were 
substantial. To reduce the economic burden of treating asthma patients and 
enhance productivity, this study further highlights the importance of weight 
control.  
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DRIVERS OF RESOURCE UTILIZATION IN PATIENTS WITH AUTOSOMAL 
DOMINANT POLYCYSTIC KIDNEY DISEASE  
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OBJECTIVES: Polycystic kidney disease (PKD) is a genetic disorder affecting 
nearly 1 in 1000 Americans. Autosomal dominant PKD (ADPKD) occurs in both 
children and adults with symptoms often occurring in middle age. The objective 
of this retrospective study was to assess hospital-based utilization among 
patients with ADPKD. METHODS: A retrospective study of 1409 patients 
hospitalized in 2009 with a diagnosis of ADPKD in 71 hospitals continuously 
submitting over 36 months from the MedAssets health system database was 
conducted. Subsequent hospital visits were identified over a 24 month follow-up 
period. Age and gender as well as clinical complications, comorbidities and 
measures of utilization including number of visits and length of stay (LOS) were 
described. Multivariate regression was used to identify significant drivers of 
hospital-based utilization. RESULTS: The sample population had a mean age of 
50.6 years and was 51% male. Patients had an average of 17 outpatient and 2.5 
inpatient visits. Average LOS was 20.6 days, 45% were diagnosed with end stage 
renal disease (ESRD) and 24% received hemodialysis. Over 15.0% required a 
kidney transplant while 3.3% died in the hospital. Comorbidities included 
diabetes 21.9%, congestive heart failure (CHF) 12.6%, cardiopulmonary disease 
(CPD) 14.7%, cardiovascular disease (CVD) 11.3% and malignancy/tumor 12.3%. 
ESRD (1.3 visits, P<0.001), kidney transplant (2.0 visits, p<.0001), (1.4 visits, 
p<.0001), CPD (1.3 visits, p<.0001), CVD (1.4 visits, p<.0001), malignancy (1.3 visits, 
p<0.05) and previous myocardial infarction (1.3 visits, p<0.05) were associated 
with more visits. Similarly, ESRD (1.8 days, <.0001) and kidney transplant (1.5 
days, p=0.0005) were significantly associated with higher inpatient LOS. 
CONCLUSIONS: Patients with ADPKD consume a significant amount of health 
care resources, especially patients reaching the end stage of the disease. Further 
research is required to understand the effect of interventions/treatments on 
mitigating the progress of this disease.  
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SHORT-TERM RELATIONSHIPS BETWEEN ELECTRONIC HEALTH  
RECORD SYSTEM INTEGRITY IN EMERGENCY DEPARTMENTS AND  
HEALTH CARE RESOURCE UTILIZATION AMONG PATIENTS WITH  
MENTAL DISORDERS  
Tang DH, Warholak TL 
The University of Arizona, Tucson, AZ, USA  
OBJECTIVES: To assess patient emergency department (ED) waiting time, 
hospitalization rate immediately following ED visit, number of medications 
prescribed, and length of stay in ED among practices with various levels  
of electronic health record (EHR) functionality pertaining to mental illness-
related ED visits. METHODS: Data from 2006-2009 Centers for Disease Control 
and Prevention National Hospital Ambulatory Medical Care Survey ED files were 
used for this retrospective, cross-sectional study. Mental disorders were 
identified via: 1) International Classification of Diseases, Ninth Revision, Clinical 
Modification codes based on definitions by American Psychiatric Association’s 
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, and 2) mental 
health-related reason for visits as determined by the National Center for Health 
Statistics. EHR use among organizations was classified as no EHR, some EHR, 
basic EHR, and fully functional EHR based on the number and level of available 
features. Negative binomial regression models were applied using waiting time 
and visit length as outcome variables, while logistic and ordered logistic 
regression models were applied using hospitalization rate and number of 
medications prescribed as dependent variables, respectively. Regression 
analyses adjusted for patient demographics (age, gender, race/ethnicity, 
region/location, education, income, insurance status), level of triage and 
comorbidity, and hospital ownership status. To provide national estimates, all 
results were weighted and used standard errors calculated via Taylor-series 
approaches. RESULTS: Of the 24.3 million ED visits identified, 37.2%, 33.4%, and 
6.0% included some, basic, and fully functional EHRs, respectively. Having any 
sort of EHR was associated with 24% greater odds of hospitalization (p=0.032). 
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However, EHR use was not associated with increased wait time (pooled p=0.34), 
number of medications prescribed (pooled p=0.36), and ED visit length (pooled 
p=0.30). CONCLUSIONS: Among patients with mental disorders, EHR may 
increase short-term health care utilization but benefit patients in the long-term 
due to early treatment.  
 
PHS46  
ECONOMIC BURDEN OF PNEUMONIAE REQUIRING HOSPITALIZATION IN ITALY: 
ANALYSIS FROM AN ADMINISTRATIVE DATABASE  
Ciampichini R1, Furneri G1, Cozzolino P1, Mantovani LG2, Fornari C3, Madotto F3,  
Chiodini V3, Cesana G3 
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Milano - Bicocca, Monza, Italy  
OBJECTIVES: Pneumoniae are typical infections of the lower respiratory tract. 
The objective of this analysis was to assess the economic impact of pneumoniae 
requiring hospitalizations. METHODS: Using DENALI datawarehouse, linking 
administrative health care claims of Region Lombardy inhabitants, we detected 
all subjects who were hospitalized for pneumonia (primary diagnosis ICD-9 CM: 
480-486) during the period January 2006 – December 2008. The hospital 
admission date was used as index date. Demographic and comorbidity (Charlson 
Comorbidity Index, CCI) data were evaluated. The study estimated costs of the 
episode requiring hospitalization, and costs during the 30 days preceding and 
following the index date. Matched comparison was performed between 30-day 
per-patient costs in the post and pre-index period. RESULTS: During the study 
period, 18,516 subjects (59% male, mean age 70.8 years) experienced at least one 
hospital admission for pneumonia (around 6,000 per year). Most patients (68.4%) 
had a CCI >1 with chronic obstructive diseases and cardio-cerebrovascular 
diseases being the most common comorbidities. Overall costs for 
hospitalizations amounted to about €68mln in three years (€3,176 per-
hospitalization). The mean (median) length-of-stay was 13 days (10 days): it 
significantly increased with the increasing of CCI. Twenty-seven percent of 
patients died within 1-year following hospitalization. During the first 30-day 
post-index period, patients had significant (p<0.01) higher costs than during the 
30-day pre-index period (€36 versus €25 per-day, respectively, excluding the cost 
of the index hospitalization). Costs over the 30-day post-index period were 
mainly attributable to further hospitalizations (81.4%), followed by 
pharmacological therapy (12.7%) and ambulatory care (5.9%). Drugs for 
respiratory system and anti-infectives for systemic use were the most prescribed 
therapies in this period. CONCLUSIONS: The economic burden of pneumoniae is 
high, mainly due to the high costs of hospitalizations and relative length-of-stay. 
The comparison between the 30-day pre/post period showed the extent by which 
the acute episode triggers further health care interventions.  
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VALUE OF CHIROPRACTIC SERVICES AT AN ONSITE HEALTH CENTER  
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OBJECTIVES: To determine the influence of onsite chiropractic care on health 
care utilization and employee-reported outcomes. METHODS: A retrospective 
claims analysis and clinical evaluation were performed to assess the influence of 
onsite chiropractic services on health care utilization and outcomes. Health care 
utilization was evaluated by the likelihood of having at least 1 health care event 
(ie, health care visit, radiology procedure, musculoskeletal medication use) and 
the number of events per associate with an event. The effectiveness of care was 
evaluated for the onsite group through functional-assessment questionnaires 
appropriate to their care at each visit: the Headache Disability Index (HADI), the 
Neck Pain Disability Index (NPDI) and the Oswestry Low Back Pain Questionnaire 
(OLBQ). RESULTS: Patients treated offsite were significantly more likely to have 
physical therapy (P < 0.0001) and outpatient visits (P < 0.0001). Additionally, the 
average total number of health care visits, radiology procedures and 
musculoskeletal medication use per associate with each event were significantly 
higher for the offsite group (all P < 0.0001). Last, significant reductions in the 
HADI, NPDI, and OLBQ scores were observed (all P < 0.001), suggesting the cohort 
experienced substantial improvements in functional status for headache, neck 
pain, and low back pain respectively. CONCLUSIONS: These findings confirm 
that chiropractic services offered onsite are associated with lower health care 
utilization and improved functional status of musculoskeletal conditions. The 
former may lead to direct cost savings, and the latter indicates potential for 
reduced indirect costs, including absenteeism, presenteeism and productivity 
losses. The results of this study support the value of chiropractic services offered 
at onsite health centers through lower health care utilization and improved 
musculoskeletal function.  
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ADHERENCE TO ORAL ANTI-DIABETIC MEDICATIONS IN ANTIPSYCHOTIC 
MEDICATION USERS AND NON-USERS  
Desai P1, Adeyemi A2, Richards EK2, Lawson K1 
1The University of Texas, Austin, TX, USA, 2The University of Texas at Austin, Austin, TX, USA  
OBJECTIVES: To compare adherence to oral anti-diabetic (OAD) medications in 
users and non-users of antipsychotic medications. Among antipsychotic users, 
adherence to OADs and antipsychotics was compared. METHODS: This was a 
retrospective database analysis using Texas Medicaid prescription claims data. 
Adult patients (18-64 years) newly initiated on OADs were identified and followed 
for one-year. Medication adherence to OADs was evaluated in all patients, and 
adherence to antipsychotics was measured in the antipsychotic user cohort. 
Proportion of Days Covered (PDC) was used as the medication adherence 
measurement, with optimal adherence defined as PDC ≥ 0.8. Bivariate and 
multivariate analyses were used to compare adherence between treatment 
groups. RESULTS: A total of 18,999 patients met the study inclusion criteria of 
which 1,956 (10.30%) were prescribed antipsychotics during the study period. The 
overall mean (SD) PDC was 0.57 (0.28) for the OADs, and 0.78 (0.25) for 
antipsychotics. The mean PDC for OADs was significantly higher for antipsychotic 
users compared to non-users (0.62 vs. 0.57; p<0.0001). About 37% of antipsychotic 
users and 27% of non-users were adherent to OADs (p<0.0001). After controlling 
for age, gender, and pre-index chronic disease score, patients prescribed 
antipsychotics were 1.6 times more likely to be adherent compared to non-users 
(p<0.0001). In the subgroup of patients prescribed both medication types, higher 
PDC values were associated with antipsychotic drugs than with OADs (0.78 [0.25] 
vs 0.62 [0.29], p<0.05). CONCLUSIONS: OAD medication adherence was better 
among antipsychotic users compared to non-users in the Texas Medicaid 
population. However, overall adherence to OADs and antipsychotics was 
suboptimal in this population. The low adherence rates highlight need for 
interventions to help improve medication management for patients.  
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THE IMPACT OF RECEIVING FACE-TO-FACE MEDICATION THERAPY 
MANAGEMENT (MTM) SERVICES ON ADHERENCE TO CHRONIC MEDICATIONS: 
A RETROSPECTIVE CLAIMS ANALYSIS  
Soliman AM1, Carlson A2, MacLehose RF3, Brummel AR4, Schommer JC3 
1College of Pharmacy, University of Minnesota, Minneapolis, MN, USA, 2Data Intelligence 
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OBJECTIVES: Medication non-adherence carries significant economic and clinical 
burden. MTM services aims to optimize pharmacotherapy and improve 
medication adherence. This study evaluates the impact of face-to-face MTM 
services on medication adherence among patients taking insulin, oral 
hypoglycemics, statins, Beta-blockers and Angiotensin-Converting Enzyme 
inhibitors (ACEI). METHODS: Pharmacy claims of continuously enrolled 
employees of a large health care system were retrieved for the period 2007-2011. 
Retrospective analysis was used to compare outcomes in employees who 
received MTM (verified through MTM documentation software) to employees 
who did not (control group). MTM group’s index date was the date of the first 
MTM visit; Non-MTM group’s index date was randomly chosen from all 
therapeutic class-specific prescription claims-dates. For each therapeutic class, 
patients with at least one prescription fill in both the measurement period (365 
days post-index) and the baseline period (365 days pre-index) were included. The 
primary outcome variable was medication adherence measured as proportion of 
days covered (PDC) in the measurement period. Potential predictors including 
MTM exposure, demographics (age and sex), pre-index PDC, number of 
prescribing physicians, using mail order pharmacy, sum of copays in the 
measurement period, index year and co-morbidities were controlled for in 5 
separate multivariate linear regression models. RESULTS: MTM exposure was 
associated with higher PDC in multivariate models; the difference between 
groups was statistically significant in all therapeutic classes except for oral 
hypoglycemics [insulin (10.9%, CI:16.7%,5.1%, p=0.0002), oral hypoglycemic (3.9%, 
CI:8.4%,-0.04% p=0.08), statins (7.6%,CI:10.5%-4.8% p<0.001), beta blockers 
(4.8%,CI:0.5%-9.1%, p=0.026), ACEI (10.8%,CI:14.5%-7.1% p<0.001)]. Age, pre-index 
PDC and sum of copay were significantly associated with a higher PDC (p<0.05). 
CONCLUSIONS: Receiving MTM services resulted in higher medication 
adherence levels across multiple chronic medication classes compared to 
controls. MTM can be used by insurers/employer groups to increase rates of 
medication adherence thereby producing better clinical outcomes and lower 
health care costs.  
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THE IMPACT OF RECEIVING DIABETES SELF-MANAGEMENT EDUCATION 
(DSME) ON PREVENTIVE CARE PRACTICES AMONG TYPE-2 DIABETES ADULTS  
Gala SD, Wu WK 
St. John's University, Jamaica, NY, USA  
OBJECTIVES: DSME is a critical element of care for diabetes patients, leading to 
better outcomes. Given that one of the objectives of DSME is to prevent diabetic 
complications (retinopathy, limb amputation, etc.), we examine the impact of 
DSME on preventive care practices among type II diabetes adults. METHODS: 
Self-reported weighted data of 2,175,315 non-institutionalized type II diabetic 
adults who reported DSME and seven preventive care practices was used from 
2010 Behavioral Risk Factors Surveillance System (BRFSS). The preventive care 
practices studied were bi-annual HbA1c testing, annual dilated eye examination, 
daily Self-Monitoring of Blood Glucose (SMBG), annual foot examination, annual 
flu shot, once-in-life pneumonia vaccine and annual doctor visit. Bivariate 
analyses and multivariate logistic regression were performed using SAS® 9.2. 
RESULTS: Approximately 57% (n=1,183,476) of type II diabetes adults received 
DSME. Receiving DSME significantly increased the likelihood of obtaining all 
preventive care practices except bi-annual HbA1c test (p=0.168). After adjusting 
for covariates, those who received DSME had higher likelihood of obtaining 
annual dilated eye examination (OR=1.56, 95% CI=1.27-1.92, p<0.001), daily SMBG 
(OR=1.59, 95% CI=1.31-1.95, p<0.001), annual foot examination (OR=2.28, 95% 
CI=1.84-2.81, p<0.001), annual flu shot (OR=1.27, 95% CI=1.04-1.55, p=0.019), 
pneumonia vaccine (OR=1.49, 95% CI=1.22-1.82, p=0.001) and annual doctor visit 
(OR=1.44, 95% CI=1.07-1.93, p=0.016). Hispanic ethnicity/race, males, unmarried 
adults, low income (less than $15,000), less than high school education and non-
insulin users faced barriers to receive DSME. CONCLUSIONS: Having received 
DSME had positive impact on attainment of preventive care practices. 
